Digital Transformation of R&D Labs: How to predict the impact of innovative technologies on business goals
The pharmaceutical industry is undergoing a digital revolution to improve its R&D efficiency and leverage the power of big data to accelerate the time-to-market.
Implementing new, sometimes disruptive, technologies in the lab can give a clear competitive advantage. Several strategies such as digital lab groups or accelerator programs have been created to scout for innovative solutions and estimate their potential if scaled up to the entire company. Ultimately, the decision to implement a new technology relies on the alignment between the scientists’ needs and the business goals.
27 July 2021
15:00 – 16:00 BST
Learn from our Expert Panellists
Viral Vyas, Lead IT Business Partner, Bristol Myers Squibb
In this panel discussion, R&D IT business experts will shed light on:
- What are the optimum strategies to test new technologies in R&D labs?
- How to measure and extrapolate ROI for disruptive technologies?
- What are the current business goals for R&D labs?
- What makes a successful business case?
LabTwin is creating the next generation of digital lab tools for smart labs, starting with the world’s first voice-activated lab assistant. With LabTwin, scientists can collect data, access information, manage experiments and streamline documentation simply by talking. Using voice recognition and machine learning technology, LabTwin’s smart assistant simplifies data capture, structures valuable information, and integrates with lab instruments and informatic systems. With a mission to empower scientists, LabTwin is an independent Berlin, Germany-based company, backed by Boston Consulting Group Digital Ventures and Sartorius. Its voice-powered assistant is now used by scientists in 7 of the Top20 biopharma companies, as well as chemical companies, around the world.